Nelson Daniel Chang Velazquez is a Harker Heights, Texas based male eyecare provider who is specialized as Optician. Nelson Daniel Chang Velazquez makes / sells eyeglasses and, contact lenses, for remedying defects of vision in accordance with the prescriptions of ophthalmologists and optometrists. Opticians also specializes in filling lens prescriptions, assisting patients with lens and frame selection and fitting (including style, weight and colour) but they do not test vision or write prescriptions for visual correction.
Complete Profile:
Nelson Daniel Chang Velazquez speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Optician
Gender:
Male
Practice Address:
2020 Heights Dr, Harker Heights, Texas, 76548-2000
Phone:
254-699-4721
Fax:
254-699-4783
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1164222949
NPI Enumeration Date:
19 Mar, 2025
NPI Last Update On:
19 Mar, 2025
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Nelson Daniel Chang Velazquez are as mentioned below.
License Number
Specialization
State
Status
Optician
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
3800 Fabianna Dr, Killeen, Texas
Zip:
76549-2897
Phone Number:
865-296-8399
Fax Number:
--
Patients can reach Nelson Daniel Chang Velazquez at 2020 Heights Dr, Harker Heights, Texas or can call to book an appointment on 254-699-4721. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 April, 2025.